Literature DB >> 12927512

Using probiotics and prebiotics to improve gut health.

Kieran M Tuohy1, Hollie M Probert, Chris W Smejkal, Glann R Gibson.   

Abstract

Recent molecular-based investigations have confirmed the species diversity and metabolic complexity of the human gut microbiota. It is also increasingly clear that the human gut microbiota plays a crucial role in host health, both as a source of infection and environmental insult and, conversely, in protection against disease and maintenance of gut function. Although little is known about the health impact of the dominant groups of gut bacteria it is generally accepted that bifidobacteria and lactobacilli are important components of what might be termed the beneficial gut microbiota. The microbiota management tools of probiotics, prebiotics and synbiotics have been developed and, indeed, commercialized over the past few decades with the expressed purpose of increasing numbers of bifidobacteria and/or lactobacilli within the gastrointestinal tract.

Entities:  

Mesh:

Year:  2003        PMID: 12927512     DOI: 10.1016/s1359-6446(03)02746-6

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  56 in total

1.  Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers.

Authors:  Rosa del Campo; Daniel Bravo; Rafael Cantón; Patricia Ruiz-Garbajosa; Raimundo García-Albiach; Alejandra Montesi-Libois; Francisco-Javier Yuste; Victor Abraira; Fernando Baquero
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

2.  Bifidobacterial diversity determined by culturing and by 16S rDNA sequence analysis in feces and mucosa from ten healthy Spanish adults.

Authors:  Susana Delgado; Adolfo Suárez; Baltasar Mayo
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 3.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

4.  Coming full circle: From antibiotics to probiotics and prebiotics.

Authors:  John M Conly; Lynn B Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-05       Impact factor: 2.471

5.  Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.

Authors:  Patricia Alvarez-Sieiro; Maria Cruz Martin; Begoña Redruello; Beatriz Del Rio; Victor Ladero; Brad A Palanski; Chaitan Khosla; Maria Fernandez; Miguel A Alvarez
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-22       Impact factor: 4.813

Review 6.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

Review 7.  Prebiotics from marine macroalgae for human and animal health applications.

Authors:  Laurie O'Sullivan; Brian Murphy; Peter McLoughlin; Patrick Duggan; Peadar G Lawlor; Helen Hughes; Gillian E Gardiner
Journal:  Mar Drugs       Date:  2010-07-01       Impact factor: 5.118

8.  Effects of mannoprotein E1 in liquid diet on inflammatory response and TLR5 expression in the gut of rats infected by Salmonella typhimurium.

Authors:  Sinforiano J Posadas; Victor Caz; Isabel Caballero; Emilio Cendejas; Immaculada Quilez; Carlota Largo; Marcos Elvira; Enrique De Miguel
Journal:  BMC Gastroenterol       Date:  2010-06-08       Impact factor: 3.067

Review 9.  The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens.

Authors:  Huey-Shi Lye; Chiu-Yin Kuan; Joo-Ann Ewe; Wai-Yee Fung; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-27       Impact factor: 6.208

10.  Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse.

Authors:  Jasmina Saric; Jia V Li; Yulan Wang; Jennifer Keiser; Kirill Veselkov; Stephan Dirnhofer; Ivan K S Yap; Jeremy K Nicholson; Elaine Holmes; Jürg Utzinger
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.